Article ID Journal Published Year Pages File Type
3045642 Clinical Neurophysiology 2012 5 Pages PDF
Abstract

ObjectiveTo prospectively assess combined evoked potentials (EP) as markers and predictors of the disease course of early MS over 3 years.MethodsFifty patients in the early phase of relapsing remitting MS prospectively received visual, somatosensory and motor EP and EDSS assessments at baseline (T1) and at 6 months intervals during 3 years. Spearman rank correlation was used to determine the relationship between z-transformed EP-latencies (z-EPL) and EDSS. Multivariable linear regression was performed to predict EDSS at year 3 (T7) in function of z-EPLT1. Validity of the models was assessed using group cross-validation.ResultsAt each of the seven points in time, EDSS correlated with the sum of z-EPL (0.64 ⩽ rho ⩽ 0.79, p < 0.001). The change of the sum of z-EPLT7–T1 correlated with the change of EDSST7–T1 (rho = 0.51, p = 0.001). EDSST7 as predicted by the sum of z-scores of EP latencies or by the number of pathological EP results at baseline correlated with the observed clinical values after 3 years (rho > 0.70, p < 0.001, for both measures).ConclusionsMultimodal EPs correlate well with clinical disability in cross-sectional and longitudinal comparison in early MS and allow prediction of disease evolution over 3 years.SignificanceEPs seem well suited as markers of the disease course in early MS in clinical trials and bear potential for supporting decision-finding in individual patients.

► Multimodal evoked potentials can be summarized in a rational number which correlates well with clinical assessment in groups of patients with early MS. ► Prediction of the disease course over 3 years in patient groups is possible with a correlation coefficient of 0.7. ► Multimodal evoked potentials bear the potential to improve clinical trial design and counselling of individual patients.

Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , ,